Copy number of Epstein-Barr virus genomes per infected cell
Healthy carriers . | Patients with active PTLD . | |||||
---|---|---|---|---|---|---|
H1 . | H2 . | H3 . | H4 . | P1 . | P2 . | P3 . |
7 | 4 | 3 | 1 | 5 | 6 | 3 |
8 | 5 | 4 | 2 | 6 | 10 | 10 |
9 | 6 | 6 | 9 | 8 | 12 | 10 |
11 | 6 | 7 | 12 | 9 | 12 | 15 |
14 | 9 | 8 | 16 | 9 | 18 | 22 |
14 | 14 | 10 | 27 | 16 | 20 | 23 |
19 | 15 | 10 | 32 | 18 | 21 | 33 |
26 | 19 | 11 | 33 | 21 | 22 | 33 |
38 | 20 | 15 | 35 | 23 | 22 | 50 |
39 | 26 | 17 | 38 | 23 | 25 | 50 |
45 | 34 | 20 | 43 | 27 | 42 | 111 |
53 | 39 | 25 | 45 | 28 | 79 | 161 |
55 | 50 | 30 | 103 | 28 | 156 | 228 |
60 | 59 | 148 | 170 | 29 | 280 | 593 |
66 | 61 | 156 | 301 | 45 | 418 | 2007 |
69 | 68 | 224 | 331 | 46 | 660 | |
73 | 96 | 224 | 510 | 51 | ||
94 | 120 | 281 | 696 | 59 | ||
133 | 177 | 1263 | 63 | |||
199 | 67 | |||||
390 | 81 | |||||
84 |
Healthy carriers . | Patients with active PTLD . | |||||
---|---|---|---|---|---|---|
H1 . | H2 . | H3 . | H4 . | P1 . | P2 . | P3 . |
7 | 4 | 3 | 1 | 5 | 6 | 3 |
8 | 5 | 4 | 2 | 6 | 10 | 10 |
9 | 6 | 6 | 9 | 8 | 12 | 10 |
11 | 6 | 7 | 12 | 9 | 12 | 15 |
14 | 9 | 8 | 16 | 9 | 18 | 22 |
14 | 14 | 10 | 27 | 16 | 20 | 23 |
19 | 15 | 10 | 32 | 18 | 21 | 33 |
26 | 19 | 11 | 33 | 21 | 22 | 33 |
38 | 20 | 15 | 35 | 23 | 22 | 50 |
39 | 26 | 17 | 38 | 23 | 25 | 50 |
45 | 34 | 20 | 43 | 27 | 42 | 111 |
53 | 39 | 25 | 45 | 28 | 79 | 161 |
55 | 50 | 30 | 103 | 28 | 156 | 228 |
60 | 59 | 148 | 170 | 29 | 280 | 593 |
66 | 61 | 156 | 301 | 45 | 418 | 2007 |
69 | 68 | 224 | 331 | 46 | 660 | |
73 | 96 | 224 | 510 | 51 | ||
94 | 120 | 281 | 696 | 59 | ||
133 | 177 | 1263 | 63 | |||
199 | 67 | |||||
390 | 81 | |||||
84 |
PTLD indicates post-transplantation lymphoproliferative disease.